Publications
Le pôle Québec de l’ICRIS est à l’origine de nombreuses publications scientifiques, que vous trouverez sur cette page, répertoriées selon plusieurs catégories.
Rechercher un article par :
2025
A fMRI meta-analysis of emotion processing in the psychosis spectrum reveals no significant alterations in at-risk individuals
Pilon F, Boisvert M, Mottron L, Potvin S.
Psychiatry Res. 2025 Sep;351:116565. doi: 10.1016/j.psychres.2025.116565. Epub 2025 May 30. PMID: 40482576.
A Meta-Analysis of Task-Based fMRI Studies on Alcohol Use Disorder
Roberge M, Boisvert M, Potvin S.
Brain Sci. 2025 Jun 20;15(7):665. doi: 10.3390/brainsci15070665. PMID: 40722257; PMCID: PMC12293344
A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing
Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D.
JMIR Form Res. 2025 Jun 23;9:e71924. doi: 10.2196/71924. PMID: 40550117; PMCID: PMC12235202.
A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis
Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D.
Psychiatry Res. 2025 Aug;350:116553. doi: 10.1016/j.psychres.2025.116553. Epub 2025 May 17. PMID: 40450961
A pre-post study of the impact of a multidisciplinary model of care on linkage to hepatitis C care following release from prison: The Beyond Prison Walls study
Kronfli N, Mambro A, O’Brien A, Dussault C, Chalifoux S, Balso LD, Petropoulos A, Lim M, Halavrezos A, Lebouche B, Sebastiani G, Klein MB, Cox J.
Int J Drug Policy. 2025 Sep;143:104873. doi: 10.1016/j.drugpo.2025.104873. Epub 2025 Jun 11. PMID: 40513132
A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study
Bach P, Le Foll B, Davidson S, de Kiewit A, Bakouni H, Poulin G, Ghosh M, Jutras-Aswad D.
Contemp Clin Trials. 2025 Jun;153:107916. doi: 10.1016/j.cct.2025.107916. Epub 2025 Apr 13. PMID: 40233849
A repertoire and critical review of international resources relevant to medical assistance in dying where a mental disorder is the sole underlying medical condition
Favron-Godbout C, Foster I, Racine E.
Int J Law Psychiatry. 2025 Sep-Oct;102:102114. doi: 10.1016/j.ijlp.2025.102114. Epub 2025 Jun 23. PMID: 40554822
A Review of Reviews of Patient-Reported Measures in Psychosis: Need to Consider Factors Affecting Equity and the Involvement of Patients
Nair N, Abou Farhat M, Kaur N, Jones N, Mohan G, Boruff J, Iyer SN
Schizophr Bull Open. 2025 Jan 11;6(1):sgae032. doi: 10.1093/schizbullopen/sgae032. PMID: 40110566; PMCID: PMC11920872.
A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States
Zolopa C, Clifasefi SL, Dobischok S, Gala N, Fraser-Purdy H, Phillips MK, Blackmore S, Wendt DC.
Drug Alcohol Depend. 2025 Apr 1;269:112597. doi: 10.1016/j.drugalcdep.2025.112597. Epub 2025 Feb 12. PMID: 39970577.
Activating group II metabotropic glutamate receptors in the basolateral amygdala inhibits increases in reward seeking triggered by discriminative stimuli in rats
LeCocq MR, Mainville-Berthiaume A, Laplante I, Samaha AN.
International Journal of Neuropsychopharmacology, Volume 28, Issue 6
Altered resting-state amplitudes of low-frequency fluctuations in offspring of parents with a diagnosis of bipolar disorder or major depressive disorder
Boisvert M, Dugré JR, Potvin S.
PLoS One. 2025 Feb 18;20(2):e0316330. doi: 10.1371/journal.pone.0316330. PMID: 39965009; PMCID: PMC11835319.
An Approach to Providing Timely Mental Health Services to Diverse Youth Populations
Iyer SN, Boksa P, Joober R, Shah J, Fuhrer R, Andersson N, Lal S, D’Andrea G, Morrison N, Noel V, Rabouin D, Cowan T, MacDonald K, Levasseur MA, Poukhovski-Sheremetyev F, Abdel-Baki A, Augustine L, Friese K, Godin I, Hay K, Hutt-MacLeod D, Plourde V, Rabbitskin N, Reaume-Zimmer P, Rousseau C, Rudderham H, Abba-Aji A, Aubin D, Urichuk L, Vallianatos H, Golchi S, Winkelmann I, Chisholm-Nelson J, Malla A.
JAMA Psychiatry. 2025 Feb 26:e244880. doi: 10.1001/jamapsychiatry.2024.4880. Epub ahead of print. PMID: 40009399; PMCID: PMC11866065.
Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved
Minoyan N, Høj SB, Jutras-Aswad D, Larney S, Martel-Laferrière V, Sylvestre MP, Bruneau J.
Int J Ment Health Addict. 2025;23(3):1908-1919. doi: 10.1007/s11469-023-01207-7. Epub 2023 Dec 4. PMID: 40703246; PMCID: PMC12279887
Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments
Fischer B, Robinson T, Jutras-Aswad D.
J Public Health Policy. 2025 Jun;46(2):423-432. doi: 10.1057/s41271-025-00552-2. Epub 2025 Jan 19. PMID: 39828760
Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection
Truscello E, Wang S, Young J, Sebastiani G, Walmsley SL, Hull M, Cooper C, Klein MB.
J Infect Dis. 2025 Feb 4;231(1):e101-e112. doi: 10.1093/infdis/jiae487. PMID: 39417816; PMCID: PMC11793071.
Characterisation of treatment resistant mood disorder patients in the United Arab Emirates
Arnone D, Stip E.
Soc Psychiatry Psychiatr Epidemiol. 2025 Sep;60(9):2267-2269. doi: 10.1007/s00127-025-02878-4. Epub 2025 Apr 3. PMID: 40178593; PMCID: PMC12378496
Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland
Minett-Smith M, Mitchell HD, Clarke E, Vickerman P, Hickman M, Stone J, Walker J, Dawe J, Artenie A.
International Journal of Drug Policy, 145:104927
Characteristics of adolescent cannabis use and social context predicting problematic use: A decision tree analysis
Battista K, Haddad S, Leatherdale ST, Bélanger R.
Addict Behav. 2025 Nov;170:108445. doi: 10.1016/j.addbeh.2025.108445. Epub 2025 Jul 31. PMID: 40749297.
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018-2022
Zolopa C, Brothers TD, Leclerc P, Mary JF, Morissette C, Bruneau J, Martin NK, Hyshka E, Larney S.
Int J Drug Policy. 2025 Mar;137:104711. doi: 10.1016/j.drugpo.2025.104711. Epub 2025 Jan 21. PMID: 39842392
Classes of outpatient quality of care among individuals with substance-related disorders, based on a survey and health insurance registry
Fleury MJ, Cao Z, Grenier G, Huỳnh C, Meng X.
J Subst Use Addict Treat. 2025 Mar;170:209619. doi: 10.1016/j.josat.2024.209619. Epub 2025 Jan 2. PMID: 39755156
Clinical Practice Guideline Recommendations on Mental Health in Trauma: A Systematic Review
Bérubé M, Lapierre A, Panenka W, O’Donnell M, Bradley N, Moore L, Bourque L, Thébaud M, Archambault P, Archambault L, Turgeon AF, Macedo T, Haagsma J, Rao J, Garraway N, Menear M, Perreault M, Gagnon MA, Vasiliadis HM, Genest C, Provencher H, Stelfox HT.
JAMA Surg. 2025 Oct 1;160(10):1138-1155. doi: 10.1001/jamasurg.2025.2226. PMID: 40668549.
Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies
Chester L, Hebert FO, Jutras-Aswad D.
Addiction. 2025 Jun;120(6):1182-1183. doi: 10.1111/add.70066. Epub 2025 Apr 3. PMID: 40177708; PMCID: PMC12046481
Complex trauma: A theoretical and clinical approach
Collin-Vézina D.
Encephale. 2025 Sep 6:S0013-7006(25)00145-9. French. doi: 10.1016/j.encep.2025.06.008. Epub ahead of print. PMID: 40915956
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D.
Can J Psychiatry. 2025 Aug 28:7067437251367180. doi: 10.1177/07067437251367180. Epub ahead of print. PMID: 40874578; PMCID: PMC12394192
Corticolimbic Structural Deficits in Violent Patients with Schizophrenia
Athanassiou M, Dumais A, Zouaoui I, Fortier A, de Benedictis L, Lipp O, Tikàsz A, Potvin S.
Brain Sci. 2025 Feb 21;15(3):224. doi: 10.3390/brainsci15030224. PMID: 40149746; PMCID: PMC11940825
Development and usability testing of a multifaceted intervention to reduce low-value injury care
Bérubé M, Lapierre A, Sykes M, Grimshaw J, Turgeon AF, Lauzier F, Taljaard M, Stelfox HT, Witteman H, Berthelot S, Mercier É, Gonthier C, Paquet J, Fowler R, Yanchar N, Haas B, Lessard-Bonaventure P, Archambault P, Gabbe B, Guertin JR, Ouyang Y, Moore L; Canadian Traumatic Brain Injury Research Consortium.
BMC Health Serv Res. 2025 Jan 7;25(1):37. doi: 10.1186/s12913-024-12153-y. PMID: 39773251; PMCID: PMC11706146
Effect of strategies to improve interhospital transports of critically ill patients on safety and costs: protocol for a systematic review and meta-analysis
Severino F, Gallani MC, Mercier E, Ouellet S, Tremblay-Roy JS, Lapierre A, Malo C, Boivin A, Berube M.
BMJ Open. 2025 Jul 5;15(7):e094452. doi: 10.1136/bmjopen-2024-094452. PMID: 40617603; PMCID: PMC12228454
Experiences, impacts, and perspectives of recreational cannabis use among Indigenous communities: A scoping review
Zentner D, Dobischok S, DeGrace S, Wen RA, Wendt DC
Psychol Addict Behav. 2025 Jun;39(4):354-364. doi: 10.1037/adb0001073. Epub 2025 May 19. PMID: 40388141
Exploring housing instability through a gender lens among people who inject drugs in Montreal, Canada
Vakili F, Høj SB, Minoyan N, Udhesister S, Laferrière VM, Bruneau J, Larney S.
Drug Alcohol Rev. 2025 Apr 2. doi: 10.1111/dar.14050. Epub ahead of print. PMID: 40171634.
Exploring Pain-Severity and Psychological-Flexibility Trajectories During Group-Based Psychotherapy for Chronic Pain
Lamoureux É, Ghoussoub K, Shir Y, Martel MO, Prylutskyy Z, Pagé MG. Exploring Pain-Severity and Psychological-Flexibility Trajectories During Group-Based Psychotherapy for Chronic Pain
Int J Group Psychother. 2025 Jul;75(3):467-502. doi: 10.1080/00207284.2025.2469132. Epub 2025 Apr 18. PMID: 40249400
Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives
Bédard K, Boisvert I, Rochette M, Racine E, Martel-Laferrière V.
BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y. PMID: 39953410; PMCID: PMC11829365.
Factors and Strategies Influencing Integrated Self-Management Support for People With Chronic Diseases and Common Mental Disorders: A Qualitative Study of Canadian Primary Care Nurses’ Experience
Beaudin, J., Chouinard, M. C., Hudon, É., & Hudon, C.
Journal of advanced nursing, 10.1111/jan.16892, https://doi.org/10.1111/jan.16892
Factors associated with opioid craving, opioid intake, and opioid misuse in patients with chronic pain: insights from an ecological momentary assessment study
Bruneau A, Sirois A, Spiegler G, Bi J, Petkau S, Djoudi YL, Ware J, Alghamdi R, Nipa N, Perreault M, Pagé MG, Ware MA, Perez J, Martel MO.
Pain. 2025 Aug 22. doi: 10.1097/j.pain.0000000000003753. Epub ahead of print. PMID: 40844482
Five-Year Outcomes of a School-Based Personality-Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial
Conrod P, Stewart SH, Seguin J, Pihl R, Masse B, Spinney S, Lynch S.
Am J Psychiatry. 2025 Jan 15:appiajp20240042. doi: 10.1176/appi.ajp.20240042. Epub ahead of print. PMID: 39810554
Forces et défis des différents modèles de logement permanent avec soutien : perspective des organisations œuvrant dans le secteur au Québec
Fleury MJ, Grenier G, L’Espérance N.
Sante Publique. 2025;37(3):87-98. French. doi: 10.3917/spub.pr2.0077. PMID: 41052957
Functional connectivity of the nucleus accumbens and the amygdala in offspring of parents with bipolar or major depressive disorder
Boisvert M, Dugré JR, Potvin S.
Eur Arch Psychiatry Clin Neurosci. 2025 Aug 5. doi: 10.1007/s00406-025-02056-2. Epub ahead of print. PMID: 40762713.
General Practitioners’ Management of Individuals with Gambling Disorder: A Systematic Review of Practices, Knowledge, Attitudes and Beliefs
Tatar O, Iammatteo V, Brodeur M, Fleury MJ.
J Gambl Stud. 2025 Sep;41(3):915-933. doi: 10.1007/s10899-025-10402-1. Epub 2025 Jun 11. PMID: 40495109
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis
Artenie, A., Trickey, A., Looker, K. J., Stone, J., Lim, A. G., Fraser, H., Degenhardt, L., Dore, G. J., Grebely, J., Cunningham, E. B., Hazarizadeh, B., Low-Beer, D., Luhmann, N., Webb, P., Hickman, M., & Vickerman, P.
The Lancet, Gastroenterology & hepatology, 10(4), 315–331.
Hippocampus subfield volume reductions in treatment-resistant schizophrenia
Fortier A, Tikàsz A, Athanassiou M, Zouaoui I, Légaré N, Stip E, Lipp O, Dumais A, Potvin S.
Schizophr Res. 2025 Jun;280:10-14. doi: 10.1016/j.schres.2025.04.006. Epub 2025 Apr 13. PMID: 40209526.
How Does Self-Declared Chronic Pain Compare to Other Definitions? A Prospective Multicenter Study
Daoust R, Paquet J, Perry JJ, Yan JW, Williamson D, Castonguay V, Lavigne G, Rouleau D, Lessard J, Cournoyer A; OPUM research group.
Pain Res Manag. 2025 Jun 19;2025:5556400. doi: 10.1155/prm/5556400. PMID: 40575042; PMCID: PMC12202084
Illicit drug toxicity from opioid, stimulant or sedative use in adolescents: results of a Canadian one-time cross-sectional study
Carwana M, Moore E, Shariati H, Samji H, Chadi N.
Paediatr Child Health. 2025 Apr 1;30(4):320-326. doi: 10.1093/pch/pxae104. PMID: 40756552; PMCID: PMC12316521
Impact of Canada’s Cannabis Act on drug- and alcohol-related collisions in Québec: an interrupted time-series analysis of five major cities
Nazif-Munoz JI, Ouimet MC.
Traffic Inj Prev. 2025 Aug 19:1-9. doi: 10.1080/15389588.2025.2537145. Epub ahead of print. PMID: 40828992
Impacts of the COVID-19 Pandemic on Opioid Use Disorder and Services for American Indian and Alaska Native Communities
Parker DG, Radin S, Sorlagas N, Wendt DC.
Am Indian Alsk Native Ment Health Res. 2025;32(3):100-132. doi: 10.5820/aian.3203.2025.100. PMID: 41004195
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC
Psychol Addict Behav. 2025 Jul 28. doi: 10.1037/adb0001085. Epub ahead of print. PMID: 40720284
Integrating Indigenous Ways of Knowing Into Learning Health Systems: Moving From Learning Health Systems to Learning Communities
Melro CM, MacDonald K, Cowan T, Restoule B, Connors ETE, Marandola G, Mushquash CJ, Iyer SN.
Can J Psychiatry. 2025 Oct 1:7067437251380734. doi: 10.1177/07067437251380734. Epub ahead of print. PMID: 41032631; PMCID: PMC12488606
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis
Bastien G, McAnulty C, Sharafi H, Mahroug A, Elkrief L, Ziegler D, Dubreucq S, Juteau LC, Jutras-Aswad D.
J Addict Med. 2025 May-Jun 01;19(3):322-330. doi: 10.1097/ADM.0000000000001422. Epub 2024 Nov 26. PMID: 39591619
Launching a Living Ethics Initiative to Explore Patients’ Psychological Distress in a Highly Specialized Interdisciplinary Care Clinic
D’Anjou B, Desjardins K, Ianniruberto J, Méthot D, Poulin V, Rabasa-Lhoret R, Racine E.
Qual Health Res. 2025 Jul 18:10497323251353435. doi: 10.1177/10497323251353435. Epub ahead of print. PMID: 40681481.
Living successfully with chronic pain: Identifying the pivotal conditions needed to make it happen
Bérubé M, Singer LN, Guénette L, Bourque L, Ngomo S, Hudon A.
J Pain. 2025 Apr;29:105332. doi: 10.1016/j.jpain.2025.105332. Epub 2025 Feb 9. PMID: 39922553
Narratives in context: a cellphilm study of the social experiences of persons with psychosis from different ethnic, racial and migrant backgrounds
Xavier SM, Both A, Ferrari M, Abdel-Baki A, Serres S, van den Bogerd N, Lemmers-Jansen I, van der Ven E, Iyer SN.
Arts Health. 2025 Aug 29:1-17. doi: 10.1080/17533015.2025.2551538. Epub ahead of print. PMID: 40878786
Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences
Alunni-Menichini K, Chabot R, Guilbert-Gauthier G, Dominguez-Cancino KA, Robidoux L, L’Espérance N, Huynh C, Bertrand K, Vasilidis HM, Loslier J, de Saugy YF, Martínez P, Massamba V, Nazif-Munoz JI.
Sex Reprod Healthc. 2025 Sep;45:101129. doi: 10.1016/j.srhc.2025.101129. Epub 2025 Jul 20. PMID: 40701112.
Navigating discriminatory requests and refusals of healthcare workers: A Canadian-based inpatient hospital algorithm
Barned C, Nwafor A, Heesters AM.
Nurs Ethics. 2025 Sep 6:9697330251374153. doi: 10.1177/09697330251374153.
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D.
Harm Reduct J. 2025 Feb 8;22(1):14. doi: 10.1186/s12954-025-01157-4. PMID: 39923043; PMCID: PMC11806552.
Pain Management in Frail Hip Fracture Patients Receiving Palliative Care: A Descriptive Study
Tremblay A, Pelet S, Belzile É, Morency C, Dion N, Linsotan S, Tapp D, Benhamed A, Gagnon MA, Severino F, Bérubé M.
J Pain Symptom Manage. 2025 Aug;70(2):149-159.e6. doi: 10.1016/j.jpainsymman.2025.04.012. Epub 2025 May 6. PMID: 40339671.
Pain Management Strategies and Adverse Effects of Opioids in Patients with Neurotrauma with Acute and Chronic Pain
McGennis MÈ, Gagnon MA, Paquet J, Turgeon AF, Macedo T, Côté C, Matina MK, Verret M, Moore L, Richard-Denis A, Guénette L, Archambault L, Duval C, Bérubé M.
Neurotrauma Rep. 2025 Aug 19;6(1):686-699. doi: 10.1177/08977151251365585. PMID: 40918989; PMCID: PMC12413256
Patient Subgroups and Predictors of Improvement in Chronic Neuropathic Pain: A Trajectory-Based Analysis
Moisset X, Pagé MG, Pereira B, Choinière M.
Eur J Pain. 2025 Nov;29(10):e70137. doi: 10.1002/ejp.70137. PMID: 40990399; PMCID: PMC12459231
Pharmacists’ role in interventions addressing excessive polypharmacy: a scoping review
Ouraou R, Cossette B, Perron ME, Hudon C.
Int J Clin Pharm. 2025 Aug 2. doi: 10.1007/s11096-025-01971-7.
Predicting Fatal Drug Poisoning Among People Living with HIV-HCV Co-Infection
Bédard M, Moodie EE, Cox J, Gill J, Walmsley S, Martel-Laferrière V, Cooper C, Klein MB.
Can Liver J. 2025 Mar 12;8(2):295-308. doi: 10.3138/canlivj-2024-0060. PMID: 40677990; PMCID: PMC12269253.
Predictors of readmission to substance-related disorder treatment over a five-year period
Fleury MJ, Sharker S, Grenier G, Beaulieu M, Huỳnh C.
Int J Drug Policy. 2025 Sep 18;145:105016. doi: 10.1016/j.drugpo.2025.105016.
Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study
Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Johnson C, McCracken R.
Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5. PMID: 40563109; PMCID: PMC12199528.
Profiles of physician follow-up care, correlates and outcomes among patients affected by an incident mental disorder
Fleury MJ, Rochette L, Cao Z, Grenier G, Massamba V, Lesage A.
BMC Prim Care. 2025 Jan 11;26(1):7. doi: 10.1186/s12875-024-02674-0. PMID: 39799284; PMCID: PMC11724569
Progress Toward Hepatitis C Virus Elimination among People Living with HIV-Hepatitis C Virus Coinfection in Canada
El Sheikh MZ, Young J, Panagiotoglou D, Cooper C, Cox J, Martel-Laferrière V, Walmsley S, Klein MB.
Can Liver J. 2025 Feb 25;8(1):49-62. doi: 10.3138/canlivj-2024-0042. PMID: 40678661; PMCID: PMC12269190.
Psychotropic-associated delusional pseudo-gender dysphoria: a case report
Abdel Aziz K, Al Ammari AS, Alzaabi MS, Al Naqbi FJ, Adi MM, Aljaberi FS, Ouda ZH, Stip E.
BMC Psychiatry. 2025 Oct 10;25(1):969. doi: 10.1186/s12888-025-07450-7. PMID: 41073994; PMCID: PMC12512310
Reasons Explaining High Emergency Department Use in Patients With Mental Illnesses: Different Staff Perspectives
Fleury MJ, Ferland F, Farand L, Grenier G, Imboua A, Gaida F.
Int J Ment Health Nurs. 2025 Feb;34(1):e13442. doi: 10.1111/inm.13442. Epub 2024 Sep 27. PMID: 39334334
Reflections on the explanations of higher psychosis rates among migrant and ethnic minority populations: A critical discourse analysis
Xavier SM, Iyer SN.
Transcult Psychiatry. 2025 Feb;62(1):11-32. doi: 10.1177/13634615251326020. Epub 2025 Apr 13. PMID: 40223323; PMCID: PMC12089681
Rethinking the psychosis spectrum: A meta-analysis unveils a nonlinear discontinuity in verbal learning deficits between at-risk conditions and psychotic disorders
Pilon F, Giguère CÉ, Potvin S.
Eur Psychiatry. 2025 Sep 1;68(1):e122. doi: 10.1192/j.eurpsy.2025.10094. PMID: 40887798; PMCID: PMC12438976
Risk and protective factors associated with posttraumatic stress disorder among layperson responders to opioid overdose incidents
Jacka, B. P., Lin, N., Kiefer, R., Forkus, S. R., Raudales, A. M., Thomas, E. D., Samuels, E. A., Marshall, B. D. L., & Weiss, N. H.
Psychological Trauma: Theory, Research, Practice, and Policy, 7(1), 207–215. https://doi.org/10.1037/tra0001781
Roles of physiotherapists in primary care teams: a scoping review
Champoux, M., Poirier, A., & Hudon, C.
BMJ open, 15(2), e092276. https://doi.org/10.1136/bmjopen-2024-092276
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts
Abdel-Baki A, Ferrari M, Leblanc A, Arbaud C, Rabouin D, Roy MA, Iyer SN.
Schizophr Res. 2025 Mar;277:20-30. doi: 10.1016/j.schres.2025.02.001. Epub 2025 Feb 20. PMID: 39983366
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
London-Nadeau K, Barborini C, Haines-Saah R, Bazarov M, Bristowe S, Khorkhordina M, Lemay-Gaulin M, Gorka C, Juster RP, D’Alessio H, Chadi N.
Int J Drug Policy. 2025 Sep;143:104915. doi: 10.1016/j.drugpo.2025.104915. Epub 2025 Jul 8. PMID: 40633507.
Strategies to improve the quality of nurse triage in emergency departments: A systematic review
Ouellet S, Gallani MC, Fontaine G, Mercier É, Lapierre A, Severino F, Gélinas C, Bérubé M.
Int Emerg Nurs. 2025 Aug;81:101639. doi: 10.1016/j.ienj.2025.101639. Epub 2025 Jun 17. PMID: 40532318
Subjective cognition in schizophrenia and bipolar disorder: Complaints with SSTICS & SACCS
Stip E, Al Mugaddam F, Abdel Aziz K, Javaid SF, Nauman J, ElBarazi I, Potvin S, Tourjman V, White N.
Schizophr Res Cogn. 2025 Apr 15;41:100354. doi: 10.1016/j.scog.2025.100354. PMID: 40276686; PMCID: PMC12019415
Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update
Tatar O, Bakouni H, Abdel-Baki A, Jutras-Aswad D.
Cannabis Cannabinoid Res. 2025 Feb;10(1):11-17. doi: 10.1089/can.2024.0094. Epub 2024 Oct 24. PMID: 39446673.
The CONECT-6 case-finding tool to identify patients with complex needs: A few tips to promote understanding
Angrignon-Girouard, É., Schwarz, C., Howse, D., Aubrey, K., Bisson, M., Chouinard, M. C., Dickinson, L., Doucet, S., Dubois, M. F., Dumont-Samson, O., & Hudon, C
Journal of evaluation in clinical practice, 31(1), e14129. https://doi.org/10.1111/jep.14129
The effect of craving on retention and treatment switching under buprenorphine-naloxone and methadone models of care for non-heroin opioid use disorder: Exploratory analyses from a pragmatic, randomized controlled trial
McAnulty C, Bastien G, Abboud A, Bahremand A, Ledjiar O, Socias ME, Le Foll B, Juteau LC, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.
J Subst Use Addict Treat. 2025 Sep;176:209743. doi: 10.1016/j.josat.2025.209743. Epub 2025 Jun 24. PMID: 40571059.
The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study
Lim J, Bruneau J, Platt RW, Panagiotoglou D.
Drug Saf. 2025 Nov;48(11):1271-1280. doi: 10.1007/s40264-025-01574-1. Epub 2025 Jul 3. PMID: 40608239
The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time-series analysis
Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Hawley P, McCracken R.
CMAJ. 2025 May 11;197(18):E497-E505. doi: 10.1503/cmaj.250167. PMID: 40355138; PMCID: PMC12077321.
The effects of cannabis use disorder on cognitive functions: A meta-analysis
Pilon F, Dumais A, Giguère CÉ, Potvin S.
Addict Behav. 2025 Nov;170:108434. doi: 10.1016/j.addbeh.2025.108434. Epub 2025 Jul 14. PMID: 40675034
The Extended Modified Maltreatment Classification System (EMMCS): A validation study
Monette S, Hélie S, Esposito T, Trocmé N, Collin-Vézina D.
Child Abuse Negl. 2025 Sep;167:107587. doi: 10.1016/j.chiabu.2025.107587. Epub 2025 Jul 7. PMID: 40628192.
The hybrid space in eating disorder treatment: towards a personalized approach to integrating telehealth and in-person care
Novack K, Chadi N.
J Eat Disord. 2025 Feb 10;13(1):22. doi: 10.1186/s40337-025-01211-3. PMID: 39930535; PMCID: PMC11812227
The influence of heatwaves on traffic safety in five cities across Québec with different thermal landscapes
Nazif-Munoz JI, Gilani VNM, Rana J, Choma E, Spengler JD, Cedeno-Laurent JG.
Inj Epidemiol. 2025 Feb 28;12(1):12. doi: 10.1186/s40621-025-00564-2. PMID: 40022276; PMCID: PMC11869667
The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018-2021
Popovic N, Yang Q, Campeau L, Elliott J, Williams A, Lima VD, Sereda P, Cox J.
Can Commun Dis Rep. 2025 Jan 2;51(1):35-42. doi: 10.14745/ccdr.v51i01a05. PMID: 39781235; PMCID: PMC11709143
Transition from pediatric to adult health services: A survey of challenges, needs, and preferences of youths and parents
Racine E, Ouimet F, Gutierrez Rojas RG, Clermont MJ, Fournier A.
Health Care Transit. 2025 Jan 26;3:100095. doi: 10.1016/j.hctj.2025.100095. PMID: 39927091; PMCID: PMC11802371
Trends in accidental drug overdose mortality in Canada: An analysis from 1974 to 2023
Dasari H, Artenie A, Bruneau J, Larney S.
Int J Drug Policy. 2025 Oct 6;145:105022. doi: 10.1016/j.drugpo.2025.105022. Epub ahead of print. PMID: 41056833.
Triggered temptations: A new procedure to compare reward-seeking behaviour induced by discriminative and conditioned stimuli in rats
LeCocq, M. R., Najafipashaki, S., Casale, D., Laplante, I., & Samaha, A. N.
Psychopharmacology, 10.1007/s00213-025-06764-4.
Understanding episodic memory in schizophrenia: a functional neuroimaging meta-analysis
Hannaoui N, Boisvert M, Potvin S.
Psychiatry Res Neuroimaging. 2025 Sep;352:112022. doi: 10.1016/j.pscychresns.2025.112022. Epub 2025 Jul 16. PMID: 40701114.
Young adult drinking during the COVID-19 pandemic: Examining the role of anxiety sensitivity, perceived stress, and drinking motives
Corran C, Norman P, O’Connor RM.
J Am Coll Health. 2025 Jan 6:1-9. doi: 10.1080/07448481.2024.2440761. Epub ahead of print. PMID: 39761074
2024
À VENIR
2023
À VENIR
2022
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
McAnulty, C., Bastien, G., Socias, E., Bruneau, J., Le Foll, B., Lim, R., Brissette, S., Ledjiar, O., Marsan, S., Talbot, A., Jutras-Aswad, D.
Drug and Alcohol Dependence 239 (2022) 109604
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Jutras-Aswad, D., Le Foll, B., Ahamad, K., Lim, R., Bruneau, J., Fischer, B., Rehm, J., Wild, C., Wood, E., Brissette, S., Gagnon, L., Fikowski, J., Ledjiar, O., Masse, B., Socias, E.
American Journal of Psychiatry, Volume 179, Number 10, https://doi.org/10.1176/appi.ajp.21090964
Harm reduction in tobacco control: where do we draw the line?
Al-Hamdani M. & Manly E.
J Public Health Policy. 2022 Mar;43(1):149-154. doi: 10.1057/s41271-021-00327-5. Epub 2022 Jan 8. PMID: 34997211
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias, E., Wood, E., Le Foll, B., Lim, R., Cheol Choi, J., Yin Mok, W., Bruneau, J., Rehm, J., Wild, C., Bozinoff, N., Hassan, A., Jutras-Aswad, D.
Addiction. 2022 Oct;117(10):2662-2672. doi: 10.1111/add.15954. Epub 2022 Jun 17. PMID: 35712892; PMCID: PMC9969999.
Moral Foundations Theory Among Autistic and Neurotypical Children
Dempsey E., Moore C., Johnson S., Stewart S., & Smith I.
Front. Psychol., 13 January 2022, Sec. Human Developmental Psychology, Volume 12 – 2021 | https://doi.org/10.3389/fpsyg.2021.782610
Multidimensional analysis of adult patients’ care trajectories before a first diagnosis of schizophrenia
Vanasse, A., Courteau, J., Courteau, M., Roy, M., Stip, E., Fleury, M., Lesage, A., & Brodeur, S.
Schizophr 8, 52 (2022). https://doi.org/10.1038/s41537-022-00256-6
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses
Touesnard, N., Brothers, T. D., Bonn, M., & Edelman, E. J
Expert Rev Anti Infect Ther. 2022 Aug;20(8):1061-1065. doi: 10.1080/14787210.2022.2081152. Epub 2022 Jun 7. PMID: 35615917; PMCID: PMC10693947
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial
Hassan, Ahmed N. MD, FRCPC, MPH; Bozinoff, Nikki MD, MSc, CCFP; Jutras-Aswad, Didier MD, MSc, FRCPC; Socias, M. Eugenia MD, MSc; Stewart, Sherry H. PhD; Lim, Ron MD, CCFP, DFASAM; Le Foll, Bernard MD, PhD, MCFP; The OPTIMA Research Group.
Journal of Addiction Medicine 17(1):p e49-e56, 1/2 2023. | DOI: 10.1097/ADM.0000000000001048
Selective personality-targeted prevention of suicidal ideation in young adolescents: post hoc analysis of data collected in a cluster randomised controlled trial
Grummitt, L.R., Debenham, J., Kelly, E.V., Barrett, E.L., Champion, K.E., Conrod, P.J., Teesson, M., & Newton, N.C.
Med J Aust. 2022 Jun 6;216(10):525-529. doi: 10.5694/mja2.51536. Epub 2022 May 14. PMID: 35568380; PMCID: PMC9542662
Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison
Curtis M., Berk J., Larney S., Rich J., & Stoové M.
J Public Health Policy. 2022 Mar;43(1):149-154. doi: 10.1057/s41271-021-00327-5. Epub 2022 Jan 8. PMID: 34997211
Telehealth for people who inject drugs: An acceptable method of treatment but challenging to access
Delisle-Reda S., Bruneau,J. & Martel-Laferrière V.
Journal of Addictive Diseases, 40(4), 514–517. https://doi.org/10.1080/10550887.2022.2035166
The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study
Colledge-Frisby, S., Jones, N., Larney, S., Peacock, A., Lewer, D., Brothers, T. D., Hickman, M., Farrell, M., & Degenhardt, L.
Drug Alcohol Depend. 2022 Jul 1;236:109494. doi: 10.1016/j.drugalcdep.2022.109494. Epub 2022 May 13. PMID: 35605532.
2021
Déploiement d’un algorithme de soins en réponse à la crise des opioïdes
Annie Talbot, Rania Khemiri, Aïssata Sako, Luc Londei-Leduc, Christine Robin, Suzanne Marcotte, Guenièvre Therrien, Geneviève Goulet, Geneviève Beaudet Hillman, Christine Ouellette, Suzanne Brissette, Marcel Martin, Polina Titova, Pierre Lauzon
Drogues, santé et société, 2021
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection.
Andreea Adelina Artenie, Matthew Hickman, Peter Vickerman, Jack Stone, Jason Grebely, Julie Bruneau
International Journal of Drug Policy 96 (2021) 103419
Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip , Jean-François Cailhier, Didier Jutras-Aswad
Neuropsychopharmacol. 46, 2101–2111 (2021). https://doi.org/10.1038/s41386-021-01098-z
Framing public health response to the opioid and overdose crisis: are there alternatives to cascade of care model?
Stine Bordier Høj, Julie Bruneau, Matthew Hickman
European Journal of Public Health, Volume 31, Issue 4, August 2021, Pages 670–671, https://doi.org/10.1093/eurpub/ckab031
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting
Elena Argento, M Eugenia Socias, Kanna Hayashi, JinCheol Choi, Lindsay Mackay, Devon Christie, M-J Milloy, Kora DeBeck
Int J Drug Policy. 2022 Feb;100:103518. doi: 10.1016/j.drugpo.2021.103518. Epub 2021 Nov 7. PMID: 34758431; PMCID: PMC8890776.
2020
Applicability of the four-factor personality vulnerability model for substance misuse in understanding gambling behaviour and gambling problems.
Otis, E., Yakovenko, I., Sherry, S., Smith, M., Goldstein, A.L., Ellery, M., Loverock, A., Wild, T.C., Weilgart-Whitehead, B., & Stewart, S.
Personality and Individual Differences, Volume 169, 1 February 2021, 110400
Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?
Tibbo, P., McKee, K.A., Meyer, J., Crocker, C., Aitchison, K., Lam, R., & Crockford, D.
The Canadian Journal of Psychiatry. 2020;66(2):185-194. doi:10.1177/0706743720945525
Changes in positive and negative peer influences and depressive symptoms from adolescence to young adulthood.
Homel, J., Thompson, K., & Leadbeater, B.
J Adolesc. 2020 Oct;84:113-122. doi: 10.1016/j.adolescence.2020.08.009. Epub 2020 Sep 7. PMID: 32911178
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada
Wendt, D. C., Marsan, S., Parker, D., Lizzy, K. E., Roper, J., Mushquash, C., Venner, K. L., Lam, A., Swansburg, J., Worth, N., Sorlagas, N., Quach, T., Manoukian, K., Bernett, P., & Radin, S. M.
Journal of Substance Abuse Treatment, 2021-02-01, Volume 121, Article 108165
Corrigendum: Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences.
Noorbakhsh, S., Afzali, M., Boers, E., & Conrod, P.
Front. Hum. Neurosci. 14:95. doi: 10.3389/fnhum.2020.00095
Developing and testing the effectiveness of a novel online integrated treatment for problem gambling and tobacco smoking: a protocol for an open-label randomized controlled trial.
Bilevicius, E., Single, A., Baumgartner, C., Bui, V., Kempe, T., Schaub, M. P., Stewart, S. H., MacKillop, J., Hodgins, D. C., Wardell, J. D., O’Connor, R., Read, J., Hadjistavropoulos, H., Sundstrom, C., & Keough, M. T
Trials 21, 937 (2020). https://doi.org/10.1186/s13063-020-04867-1
Does how you use matter? The link between mode of use and cannabis-related risk.
Swan, C., Ferro, M., & Thompson, K.
Addictive Behaviors, 2021-01-01, Volume 112, Article 106620
Examining Subgroups of Depression and Alcohol Misuse in Emerging Adults During University: a Replication and Extension Study
Orui, K., Frohlich, J.R., Stewart, S.H., Sherry, S.B., & Keough, M.T.
Int J Ment Health Addiction 19, 2323–2341 (2021). https://doi.org/10.1007/s11469-020-00325-w
Facing Confinement, the Comfort of WhatsApp Groups in Mental Health Communities
Stip, E., Mugaddam, F. A., & Amiri, L.
The Canadian Journal of Psychiatry. 2020;66(1):63-64. doi:10.1177/0706743720949341
Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis.
Abdel-Baki, A., Medrano, S., Maranda, C., Ladouceur, M., Tahir, R., Stip, E., & Potvin, S.
International Clinical Psychopharmacology 35(4):p 221-228, July 2020. | DOI: 10.1097/YIC.0000000000000310
Knowledge Translation in a Community-Based Study of the Relations Among Violence Exposure, Post-traumatic Stress and Alcohol Misuse in Mi’kmaq Youth.
Zahradnik, M., Stewart, S., Stevens, D., & Wekerle, C.
First Peoples Child & Family Review, volume 4, numéro 2, 2009, p. 106–117. https://doi.org/10.7202/1069334ar
Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic.
Bartel, S.J., Sherry, S., & Stewart, S.
Substance Abuse, 41(4), 409–412. https://doi.org/10.1080/08897077.2020.1823550
Substance use disorders among youth with chronic physical illness.
Luther, A.W., Reaume, S.V., Qadeer, R.A., Thompson, K., & Ferro, M.A
Addictive Behaviors, 2020-11-01, Volume 110, Article 106517
The Development and Psychometric Testing of a Substance Use Wellness Tool
Chen, S., Stuart, H.L., Krupa, T., Dobson, K.S., & Stewart, S.H.
Canadian Journal of Community Mental Health 37(3):83-95 DOI:10.7870/cjcmh-2018-012
The Network Constellation of Personality and Substance Use: Evolution from Early to Late Adolescence
Afzali, M., Stewart, S., Séguin, J., & Conrod, P.
European Journal of Personality, 34(6), 1109-1119. https://doi.org/10.1002/per.2245 (Original work published 2020)
Understanding Steps and Challenges to Take-home Naloxone and Buprenorphine/naloxone Implementation in Québec Emergency Rooms: Suboxed Project
Talbot, A., Khemiri, R., Sako, A., Londei-Leduc, L., Robin, C., Marcotte, S., Therrien, G., Goulet, G., Beaudet-Hilman, G., Ouellette, C., Brissette, S., Martin, M., Titova, P. & Lauzon, P.
Research Square, https://doi.org/10.21203/rs.3.rs-33331/v1
2019
Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada.
Fortier E, Sylvestre MP, Artenie A, Minoyan N, Jutras-Aswad D, Roy É, Grebelyg J, Bruneau J.
Drug and Alcohol Dependence, Volume 206, 1 January 2020, 107744
Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT).
K MacNeill, C Brunelle, E DiTommaso, B Skelding
Journal of Substance Use, 25(4), 377–381. https://doi.org/10.1080/14659891.2019.1704083
Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review
MN Wilson, JA Hayden, E Rhodes, A Robinson, M Asbridge
The Journal of Pain, Volume 20, Issue 12, December 2019, Pages 1383-1393
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall B, Bruneau J, Altice F, Henderson G, Rahimi-Movaghar A, Larney S.
The Lancet, Volume 394, Issue 10208, 1560 – 1579
Impact of substance use and mental health comorbidity on health care access in Canada.
G Dao, C Brunelle, D Speed
J Dual Diagn. 2019 Oct-Dec;15(4):260-269. doi: 10.1080/15504263.2019.1634856. Epub 2019 Jul 7. PMID: 31282295.
Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients
Mahu IT, Conrod J, Barrett SP, Sako A, Swansburg J, Lawrence M, Laroque F, Morin JF, Chinneck A, Nogueira-Arjona R, Stewart SH.
Addictive Behaviors, Volume 98, November 2019, 106056
2018
A prospective observational study of problematic oral cannabinoid use.
Ware MA, Martel MO, Jovey R, Lynch ME, Singer J.
Psychopharmacology (Berl). 2018 Feb;235(2):409-417. doi: 10.1007/s00213-017-4811-6. Epub 2017 Dec 17. PMID: 29250737
Association between binge drug use and suicide attempt among people who inject drugs
Fournier C, Ghabrash MF, Artenie A, Roy E, Zang G, Bruneau J, Jutras-Aswad D.
Subst Abus. 2018;39(3):315-321. doi: 10.1080/08897077.2017.1389800. Epub 2017 Nov 13. PMID: 28991519.
Associations between self-reported lifetime history of traumatic brain injuries and current disability assessment in a population sample of Canadian adults.
Ilie G, Adlaf EM, Mann RE, Ialomiteanu A, Hamilton H, Rehm J, Asbridge M, Cusimano MD.
PLoS One. 2018 Jan 5;13(1):e0188908. doi: 10.1371/journal.pone.0188908. PMID: 29304117; PMCID: PMC5755742.
Changes in coping and social motives for drinking and alcohol consumption across the menstrual cycle.
Joyce KM, Hudson A, O’Connor R, Thompson K, Hodgin M, Perrot T, Stewart SH.
Depress Anxiety. 2018 Apr;35(4):313-320. doi: 10.1002/da.22699. Epub 2017 Dec 15. PMID: 29244908
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence
Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT
Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8. PMID: 28593748
Management of opioid use disorders: a national clinical practice guideline.
Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, Wild C, Wood E; on behalf of the CIHR CRISM
CMAJ March 05, 2018 190 (9) E247-E257; DOI: https://doi.org/10.1503/cmaj.170958
2017
A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial.
O’Leary-Barrett M, Mâsse B, Pihl RO, Stewart SH, Séguin JR, Conrod PJ.
Addiction. 2017 Oct;112(10):1871-1881. doi: 10.1111/add.13876. Epub 2017 Jul 17. Erratum in: Addiction. 2018 Mar;113(3):581. doi: 10.1111/add.14155. PMID: 28544009.
A Qualitative Study of Addiction Help-Seeking in People with Different Co-occurring Mental Disorders and Substance Use Problems.
Motta-Ochoa R, Bertrand K, Flores-Aranda J, Patenaude C, Brunelle N, Landry M, Brochu S.
International Journal of Mental Health and Addiction 15(1) DOI:10.1007/s11469-017-9762-y
A Review of CBT Treatments for Substance Use Disorders.
Morin JF G, Harris M, Conrod PJ.
Oxford Handbook Topics in Psychology (online edn, Oxford Academic, 3 Mar. 2014), https://doi.org/10.1093/oxfordhb/9780199935291.013.57
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
Cunningham EB, Hajarizadeh B, Dalgard O, Amin J, Hellard M, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Bruneau J, Midgard H, Bourgeois S, Thurnheer MC, Dore GJ, Grebely J; ACTIVATE Study Group.
BMC Infect Dis. 2017 Jun 13;17(1):420. doi: 10.1186/s12879-017-2517-3. PMID: 28610605; PMCID: PMC5470219.
Alcohol use among Inuit pregnant women: Validity of alcohol ascertainment measures over time
Fortin M, Muckle G, Jacobson SW, Jacobson JL, Bélanger RE.
Neurotoxicol Teratol. 2017 Nov;64:73-78. doi: 10.1016/j.ntt.2017.10.007. Epub 2017 Oct 24. PMID: 29079497.
Distinct pathological profiles of inmates showcasing cluster B personality traits, mental disorders and substance use regarding violent behaviors
Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R.
American Journal of Public Health 107, e1_e12, https://doi.org/10.2105/AJPH.2017.303818